Staar Surgical (NASDAQ: STAA)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-03 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.080 | 0.290 | 0.2100 | ||||
REV | 60.530M | 63.200M | 2.670M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Staar Surgical (NASDAQ: STAA) through any online brokerage.
Other companies in Staar Surgical’s space includes: RxSight (NASDAQ:RXST), Meridian Bioscience (NASDAQ:VIVO), BioLife Solns (NASDAQ:BLFS), Embecta (NASDAQ:EMBC) and Align Tech (NASDAQ:ALGN).
The latest price target for Staar Surgical (NASDAQ: STAA) was reported by Canaccord Genuity on Tuesday, April 26, 2022. The analyst firm set a price target for 89.00 expecting STAA to rise to within 12 months (a possible 23.29% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Staar Surgical (NASDAQ: STAA) is $72.19 last updated July 1, 2022, 8:00 PM UTC.
There are no upcoming dividends for Staar Surgical.
Staar Surgical’s Q2 earnings are confirmed for Wednesday, August 3, 2022.
There is no upcoming split for Staar Surgical.
Staar Surgical is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.